Jihye Yun, Ph.D.
Affiliations: | 2009 | Johns Hopkins University, Baltimore, MD |
Area:
Genetics, Medicine and SurgeryGoogle:
"Jihye Yun"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Bert Vogelstein | grad student | 2009 | Johns Hopkins | |
| (Glucose deprivation selects for KRAS and BRAF mutations in colorectal cancer.) | ||||
| Lewis C. Cantley | post-doc | Weill Cornell Medical College | ||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ngo B, Van Riper JM, Cantley LC, et al. (2019) Targeting cancer vulnerabilities with high-dose vitamin C. Nature Reviews. Cancer |
| Goncalves MD, Lu C, Tutnauer J, et al. (2019) High-fructose corn syrup enhances intestinal tumor growth in mice. Science (New York, N.Y.). 363: 1345-1349 |
| Goncalves M, Lu C, Hartman T, et al. (2019) SAT-LB057 High-Fructose Corn Syrup Enhances Intestinal Tumor Growth in Mice Journal of the Endocrine Society. 3 |
| Shim H, Wu C, Ramsamooj S, et al. (2016) Deletion of the gene Pip4k2c, a novel phosphatidylinositol kinase, results in hyperactivation of the immune system. Proceedings of the National Academy of Sciences of the United States of America |
| Yun J, Mullarky E, Lu C, et al. (2015) Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH. Science (New York, N.Y.) |
| Roper J, Sinnamon MJ, Coffee EM, et al. (2014) Combination PI3K/MEK inhibition promotes tumor apoptosis and regression in PIK3CA wild-type, KRAS mutant colorectal cancer. Cancer Letters. 347: 204-11 |
| Parkhitko AA, Priolo C, Coloff JL, et al. (2014) Autophagy-dependent metabolic reprogramming sensitizes TSC2-deficient cells to the antimetabolite 6-aminonicotinamide. Molecular Cancer Research : McR. 12: 48-57 |
| Yun J, Kavalier A, Mullarky E, et al. (2014) Abstract 2951: Vitamin C is selectively toxic to cancer cells harboring KRAS or BRAF mutations by targeting GAPDH Cancer Research. 74: 2951-2951 |
| Yun J, Kavalier A, Roper J, et al. (2013) Abstract C60: Vitamin C inhibits the survival and growth of colorectal cancer cells with KRAS or BRAF mutations Cancer Research. 73 |
| Yun J, Poulogiannis G, Brower ET, et al. (2013) The PI3K pathway in colorectal cancers Molecular Pathogenesis of Colorectal Cancer. 157-199 |